Suppr超能文献

大鼠中脑谷氨酸能突触终末中功能性ATP和二核苷酸受体的存在。

Presence of functional ATP and dinucleotide receptors in glutamatergic synaptic terminals from rat midbrain.

作者信息

Gualix Javier, Gómez-Villafuertes Rosa, Díaz-Hernández Miguel, Miras-Portugal M Teresa

机构信息

Departamento de Bioquímica, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.

出版信息

J Neurochem. 2003 Oct;87(1):160-71. doi: 10.1046/j.1471-4159.2003.01975.x.

Abstract

Glutamatergic terminals from rat midbrain were characterized by immunolocalization of synaptophysin and the vesicular glutamate transporters, either VGLUT1 or VGLUT2. Terminals containing these markers represent about 31% (VGLUT1) and 16% (VGLUT2) of the total synaptosomal population. VGLUT1-positive glutamatergic terminals responded to ATP or P1,P 5-di(adenosine-5') pentaphosphate (Ap5A) with an increase in the intrasynaptosomal calcium concentration as measured by a microfluorimetric technique in single synaptosomes. Roughly 20% of the VGLUT1-positive terminals responded to ATP, 13% to Ap5A and 11% to both agonists. Finally 56% of the terminals labeled with the anti-VGLUT1 antibody did not show any calcium increase in response to ATP or Ap5A. A similar response distribution was also observed in the VGLUT2-positive terminals. The Ca2+ responses induced by ATP and Ap5A in the glutamatergic terminals could be selectively inhibited by pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS, 80 micro m) and P1,P 5-di(inosine-5') pentaphosphate (Ip5I, 100 nm), respectively. Both ATP and Ap5A, once assayed in the presence of extrasynaptosomal calcium, were able to induce a concentration-dependent glutamate release from synaptosomal populations, EC50 values being 21 micro m and 38 micro m for ATP and Ap5A, respectively. Specific inhibition of glutamate release was obtained with PPADS on the ATP effect and with Ip5I on the dinucleotide response, indicating that separate receptors mediate the secretory effects of both compounds.

摘要

通过对突触素以及囊泡谷氨酸转运体VGLUT1或VGLUT2进行免疫定位,对来自大鼠中脑的谷氨酸能终末进行了表征。含有这些标志物的终末分别占突触体总数的约31%(VGLUT1)和16%(VGLUT2)。VGLUT1阳性的谷氨酸能终末对ATP或P1,P5 - 二(腺苷 - 5')五磷酸(Ap5A)有反应,通过单突触体中的微荧光技术测量,突触体内钙浓度会升高。大约20%的VGLUT1阳性终末对ATP有反应,13%对Ap5A有反应,11%对两种激动剂都有反应。最后,用抗VGLUT1抗体标记的终末中有56%对ATP或Ap5A没有显示出任何钙升高。在VGLUT2阳性终末中也观察到了类似的反应分布。谷氨酸能终末中由ATP和Ap5A诱导的Ca2+反应可分别被磷酸吡哆醛 - 6 - 偶氮苯 - 2',4' - 二磺酸(PPADS,80 μM)和P1,P5 - 二(肌苷 - 5')五磷酸(Ip5I,100 nM)选择性抑制。一旦在突触体外钙存在的情况下进行检测,ATP和Ap5A都能够诱导突触体群体中浓度依赖性的谷氨酸释放,ATP和Ap5A的EC50值分别为21 μM和38 μM。用PPADS对ATP的作用以及用Ip5I对二核苷酸反应进行特异性抑制谷氨酸释放,表明不同的受体介导了这两种化合物的分泌作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验